# ReviR Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/revir-therapeutics

- Industry: Biotechnology
- Headquarters: South San Francisco, US
- Website: www.revirtx.com
- Total disclosed funding: $30M
- Latest round: Series A (Jul 26, 2024)
- Investors on record: 6

## About

Based in Shenzhen, China, and established in 2021, ReviR Therapeutics is a research and development of a new drug company that focuses on target RNA small molecule drugs field. The company has an additional office in Silicon Valley. The company's core team members are from medical corporations, such as Gilead Sciences, AbbVie, Invitae, who engaged in drug discovery, computational chemistry, and computational biology for nearly 20 years. The co-founder as well as the CEO, Peng Yue, was a director of Computational Biology at AbbVie/Stemcentrx. In July 2024, ReviR Therapeutics raised USD 30 million in series A funding.

ReviR Therapeutics established voyageR™ AI platform that developed target small molecule drugs to treat tumour, rare diseases. The platform takes the technologies of artificial intelligence algorithms and genes sequencing to analyse structure of RNA. The drugs can be used to treat tumours and other rare diseases.

The company generates revenue by developing and providing targeted RNA small molecule drugs.

The company will build the AI ??drug development platform VoyageR, and advance the preclinical and clinical development of existing pipelines related to neurological diseases such as Huntington's disease (HD) and amyotrophic lateral sclerosis (ALS).

## Funding rounds

- Series A, Jul 26, 2024, $30M — CDH Investments, 5Y Capital, Lapam Capital, XtalPi Inc., Yael Capital, CMT Research Foundation
- Angel, May 1, 2021 — CDH Investments, 5Y Capital

## Investors

- CDH Investments (https://capitalatlas.ai/funds/cdh-investments) — Angel, Series A
- 5Y Capital (https://capitalatlas.ai/funds/5y-capital) — Angel, Series A
- Lapam Capital (https://capitalatlas.ai/funds/lapam-capital) — Series A
- XtalPi Inc. — Series A
- Yael Capital (https://capitalatlas.ai/funds/yael-capital) — Series A
- CMT Research Foundation — Series A